Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Baker

Showing results (181-190 of 200) with videos related to

Pageof 20
Sort By:
The AAPS Journal|July 19, 2022
Current Approaches for Predicting Human PK for Small Molecule Development Candidates: Findings from the IQ Human PK Prediction Working Group SurveyCarl Petersson, Xin Zhou, Joerg Berghausen, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2011
The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonistsSusan Napier, Grant Wishart, William Arbuckle, et al.
Plos One|July 19, 2017
A human tissue-based functional assay platform to evaluate the immune function impact of small molecule inhibitors that target the immune systemCristina St Pierre, Jane Guo, John D Shin, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2009
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthmaSally E Wenzel, Peter J Barnes, Eugene R Bleecker, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2018
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary AngioedemaWilliam R Lumry, Timothy Craig, Bruce Zuraw, et al.
Nature Communications|November 17, 2025
β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cellsKlaire Yixin Fjæstad, Astrid Zedlitz Johansen, Hannes Linder, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonistsTakao Kiyoi, Julia M Adam, John K Clark, et al.
Micromachines|April 3, 2019
Magnetically Aligned Nanorods in Alginate Capsules (MANiACs): Soft Matter Tumbling Robots for Manipulation and Drug DeliveryLamar O Mair, Sagar Chowdhury, Genaro A Paredes-Juarez, et al.
The Medical Journal of Australia|May 5, 2026
Australian Consensus Statement on the Prevention and Management of Frailty Among Community-Dwelling Older Adults: A Modified Delphi StudySakshi Chopra, Ida Tornvall, Natasha Reid, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2011
Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Pageof 20

Showing results (181-190 of 200) with videos related to

Sort By:
Pageof 20
The AAPS Journal|July 19, 2022
Current Approaches for Predicting Human PK for Small Molecule Development Candidates: Findings from the IQ Human PK Prediction Working Group SurveyCarl Petersson, Xin Zhou, Joerg Berghausen, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2011
The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonistsSusan Napier, Grant Wishart, William Arbuckle, et al.
Plos One|July 19, 2017
A human tissue-based functional assay platform to evaluate the immune function impact of small molecule inhibitors that target the immune systemCristina St Pierre, Jane Guo, John D Shin, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2009
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthmaSally E Wenzel, Peter J Barnes, Eugene R Bleecker, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2018
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary AngioedemaWilliam R Lumry, Timothy Craig, Bruce Zuraw, et al.
Nature Communications|November 17, 2025
β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cellsKlaire Yixin Fjæstad, Astrid Zedlitz Johansen, Hannes Linder, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonistsTakao Kiyoi, Julia M Adam, John K Clark, et al.
Micromachines|April 3, 2019
Magnetically Aligned Nanorods in Alginate Capsules (MANiACs): Soft Matter Tumbling Robots for Manipulation and Drug DeliveryLamar O Mair, Sagar Chowdhury, Genaro A Paredes-Juarez, et al.
The Medical Journal of Australia|May 5, 2026
Australian Consensus Statement on the Prevention and Management of Frailty Among Community-Dwelling Older Adults: A Modified Delphi StudySakshi Chopra, Ida Tornvall, Natasha Reid, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2011
Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Pageof 20